HomeAI · summaries
Storia in 7 fonti
This multi-cancer blood test might not be useful after all
A major clinical trial involving 142,000 NHS patients revealed that the Galleri blood test for detecting over 50 cancers failed to reduce late-stage cancer diagnoses.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
healio.com
Trial of early cancer detection test misses primary endpoint; secondary data ‘promising’
CHICAGO — The first randomized trial to evaluate whether a multicancer early detection test using a blood sample could result in diagnosis at earlier stages yielded mixed…
- ·
medpagetoday.com
Multicancer Early Detection Test Fails to Reduce Cancers Detected at Late Stages
However, an increase in the detection of stage I/II cancers was observed
- ·
mirror.co.uk
'Holy grail' blood test to help NHS diagnose different cancers fails in trial
NHS hopes dashed after trial of the first multi-cancer blood test it had hoped would revolutionise treatment - but scientists say all may not be lost
- ·
independent.co.uk
New blood test ‘offers genuine hope’ it can detect cancer before symptoms appear
The test is ‘feasible at scale’ on the NHS, say researchers
- ·
Cancer-detecting blood test ‘feasible at scale’ on NHS
Stay up to date with notifications from The IndependentNotifications can be managed in browser preferences.Jump to contentThank you for registeringPlease refresh the page or…
- ·
dailymail.com
'Holy Grail' blood test could prevent one in five cancer deaths
A pioneering blood test that can detect more than 50 cancers before symptoms appear could save tens of thousands of lives a year, promising new research suggests.
- ·
newsbytesapp.com
This multi-cancer blood test might not be useful after all
A major clinical trial involving 142,000 NHS patients revealed that the Galleri blood test for detecting over 50 cancers failed to reduce late-stage cancer diagnoses.
- ·
ynetnews.com
A single blood test finds more early cancers than Britain’s screening programs combined in a trial
Data presented at ASCO show Galleri detected more early-stage cancers than all existing UK screening programs combined and sharply increased diagnoses in a US real-world study;…